My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
April 2010
Policy & Advocacy
FDA Advisory Committees Seek New Members

The Food and Drug Administration (FDA) has many advisory committees and panels of independent experts to advise on scientific, technical, and policy matters. FDA has asked IDSA to nominate individual members for these committees, which need to be replenished periodically. If you are interested in being nominated, please send your CV to Padma Natarajan at pnatarajan@idsociety.org. IDSA’s Board of Directors will consider applicants for nomination. Below is a list of relevant advisory committees with a brief description of each.  More information also can be found on the FDA Advisory Committee website.

  • Antiviral Drugs Advisory Committee: reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of AIDS, HIV-related illnesses, and other viral, fungal, and mycobacterial infections
  • Anti-Infective Drugs Advisory Committee: reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of infectious diseases and disorders
  • Microbiology Devices Panel: reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including microbiology, virology, and infectious diseases
  • Vaccines and Related Biological Products Advisory Committee: reviews and evaluates data concerning the safety, effectiveness, and appropriate use of vaccines and related biological products used in the prevention, treatment, or diagnosis of human diseases, and, as required, any other product for which the FDA has regulatory responsibility

How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
From the President: Working with our Federal Partners to Address Antibiotic Resistance
Health Reform Will Affect How ID Physicians Are Paid
IDSA Journal Club
Patient Care and Science
Special Review Panel Upholds IDSA’s 2006 Lyme Disease Guidelines
EIN Update: Invasive Group A Streptococcal (GAS) Infections
Drug Approvals, Recalls, Adverse Events Update
Practice Management
Medicare Again Postpones Physician Payment Cuts
New Medicare ID Utilization Data Now Available
Global ID
New MDR-TB Treatment Program Has Early Success
Policy & Advocacy
FDA Advisory Committees Seek New Members
Your Colleagues
Welcome, New Members!
Education & Resources
Redesigned ID/HIV Career Center Offers New Features
Revised CPT Coding Resources Coming Soon
Slides from Billing and Coding Webinar Now Available

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.